Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00076557
Status:
TERMINATED
Last Update Posted:
2007-04-04
First Post:
2004-01-26
Brief Title:
Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Sponsor:
Avigen
Organization:
Avigen
Organization Data
Organization:
Avigen
Class:
INDUSTRY
Study ID:
BB IND 9398
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Avigen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Royal Prince Alfred Hospital Sydney Australia | OTHER |
| Stanford University | OTHER |
| Childrens Hospital of Philadelphia | OTHER |
| The Hemophilia Center of Western Pennsylvania | OTHER |
| University of Washington | OTHER |
| The University of Texas Health Science Center Houston | OTHER |
| University of Campinas Brazil | OTHER |
| Christian Medical College Vellore India | OTHER |